Hyperbilirubinemic model sera with different bilirubin/albumin (Br/Alb) molar ratio, containing unconjugated bilirubin only, and containing various fractions of conjugated and unconjugated bilirubin, were simultaneously run through small columns packed with Sephadex G-25 and Sephadex LH-20. The bilirubin adsorbed by the gel was detected by a diazo-reagent and also recovered with chloroform. The amount of bilirubin adsorbed by the gel was higher using the Sephadex LH-20 gel, when sera containing unconjugated bilirubin were tested. In case of sera containing also conjugated pigment, the bilirubin adsorbed by the two gels was the same at a Br/Alb molar ratio equal to or below 0.89; above this level the bilirubin adsorbed by the Sephadex LH-20 was higher. But with reference to the concentration of the unconjugated bilirubin the chloroform-recovered bilirubin was in greater amount than expected if unconjugated bilirubin were considered in the tested sera. The possible implication of the role played by the conjugated fraction is discussed in relation also to the clinical application of the gel filtration technique.

Keywords:
‘Free’ non-albumin-bound unconjugated bilirubin, Gel filtration, Risk of bilirubin encephalopathy
This content is only available via PDF.
© 1977 S. Karger AG, Basel
1977
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.